Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Risk! That's why I'm here

<< Previous

Bullboard Posts

Next >>

Comment by Peladawnon Dec 19, 2024 4:52pm

113 Views

Post# 36371090

RE:RE:RE:RE:RE:RE:RE:RE:RE:Risk! That's why I'm here

Venture....if Oncy is selling several 100k shares on the open market to raise capital, why on earth would the sp increase 20%....if that was the case, let's hope they do it for next 30 days or so, and we'll all be rich!

<< Previous

Bullboard Posts

Next >>

Crypto and blockchain stock ends year with a profit